|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.87 USD | -0.04% |
|
-.--% | - |
| 25-04-15 | J&J Boosts Outlook Despite Incoming Tariff Costs -- Update | DJ |
| 25-04-15 | J&J Increases Outlook After Beating 1Q Expectations | DJ |
Performance
| 1 day | -0.04% | ||
| 3 years | +111.77% | ||
| 5 years | +221.63% | ||
| 10 years | +232.42% |
Volumes
marketsDaily volume
16,062,974
Estimated daily volume
16,062,974
Record volume 1
66,484,060
Record volume 2
43,993,210
Record volume 3
35,895,074
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
14,021,467,030
Net sales ()
680,852,000
Number of employees
860
Sales / Employee (USD)
791,688
Free-Float
95.68 %
Free-Float capitalization (USD)
13,440,685,967
Indicators
Moving average 5 days
131.84
Moving average 100 days
109.74
Price spread / (MMA5)
-0.02%
Price spread / (MMA100)
-16.78%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | -.--% | -.--% | +111.77% | 14.02B | |
| +4.07% | +8.45% | +25.67% | -2.34% | 66.11B | |
| -0.24% | -3.13% | +49.38% | +223.97% | 55.3B | |
| +1.21% | +42.20% | +42.20% | +42.20% | 42.44B | |
| -0.82% | +7.25% | -50.38% | -53.89% | 41.28B | |
| -2.48% | +13.91% | +166.79% | -32.89% | 32.46B | |
| -1.32% | -4.79% | +58.07% | -25.22% | 30.78B | |
| +2.10% | +4.14% | +75.49% | +90.19% | 23.1B | |
| 0.00% | +9.55% | +5.63% | +188.26% | 20.06B | |
| -0.04% | +3.85% | +67.76% | +135.89% | 17.19B | |
| Average | +0.25% | +4.16% | +44.06% | +67.79% | 34.27B | |
| Weighted average by Cap. | +0.59% | +4.17% | +41.90% | +57.52% |
Historical Quotes: Intra-Cellular Therapies, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 3 years | 45.5 |  | 131.98 |
| 5 years | 28.4 | | 131.98 |
| 10 years | 6.75 | | 131.98 |
Monthly variations
Annual variations
| 2025 | +57.89% | ||
| 2024 | +16.62% | ||
| 2023 | +35.34% | ||
| 2022 | +1.11% | ||
| 2021 | +64.59% | ||
| 2020 | -7.32% | ||
| 2019 | +201.23% | ||
| 2018 | -21.34% | ||
| 2017 | -4.04% | ||
| 2016 | -71.95% | ||
| 2015 | +204.76% | ||
| 2014 | -11.75% | ||
| 2013 | +100.00% |
- Stock Market
- Stocks
- ITCI Stock
- Quotes Intra-Cellular Therapies, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
